IVOZFO DIN 02488086
Status: Marketed
Holder: VERITY PHARMACEUTICALS INC.
Molecule: FOSFOMYCIN (FOSFOMYCIN SODIUM)
Available to quote
Health Canada record
| Active ingredient(s) | FOSFOMYCIN (FOSFOMYCIN SODIUM) 4 G |
|---|---|
| Dosage form | Powder For Solution |
| Route | Intravenous |
| Schedule | PRESCRIPTION |
| Class | Human |
| ATC | J01XX01 FOSFOMYCIN |
| Original market date | 12-Feb-2020 |
| Current status date | 12-Feb-2020 |
| Source | Health Canada DPD |
Establishment licence of the holder
Verity Pharmaceuticals Inc. — licence 3-002542, currently licensed, last inspection rating C (2023-12-19).
No Canadian shortage report is currently matched to this DIN.
Other Canadian products containing FOSFOMYCIN (FOSFOMYCIN SODIUM)
| DIN | Product | Company | Form | Strength | Status |
|---|---|---|---|---|---|
| 02488078 | IVOZFO | VERITY PHARMACEUTICALS INC. | Powder For Solution | FOSFOMYCIN (FOSFOMYCIN SODIUM) 2 G | Approved |
| 02488094 | IVOZFO | VERITY PHARMACEUTICALS INC. | Powder For Solution | FOSFOMYCIN (FOSFOMYCIN SODIUM) 8 G | Approved |
Notices of Compliance
| NOC | Date | Submission | Reason |
|---|---|---|---|
| 22103 | 2019-05-01 | New Drug Submission (NDS) |